Eltrombopag-induced clinically negligible negative bias in creatinine measurements using enzymatic assays
Clin Chem Lab Med
.
2026 Apr 7;64(8):e193-e195.
doi: 10.1515/cclm-2026-0216.
Print 2026 Jul 24.
Authors
Shun Oda
1
2
,
Kosuke Doki
1
2
,
Naoshi Obara
3
4
,
Mamiko Sakata-Yanagimoto
3
4
5
,
Masato Homma
1
2
Affiliations
1
Department of Pharmaceutical Sciences, 13121 Graduate School of Comprehensive Human Sciences, University of Tsukuba , Tsukuba, Ibaraki, Japan.
2
Department of Pharmacy, University of Tsukuba Hospital, Tsukuba, Ibaraki, Japan.
3
Department of Hematology, Institute of Medicine, University of Tsukuba, Tsukuba, Ibaraki, Japan.
4
Department of Hematology, University of Tsukuba Hospital, Tsukuba, Ibaraki, Japan.
5
Division of Advanced Hemato-Oncology, Transborder Medical Research Center, University of Tsukuba, Tsukuba, Ibaraki, Japan.
PMID:
41956092
DOI:
10.1515/cclm-2026-0216
No abstract available
Keywords:
aplastic anemia; assay interference; creatinine measurements; eltrombopag.
Publication types
Letter